Skip to main content

Table 3 Association of intestinal microsporidiosis with demographics and clinical characteristics of HIV/AIDS patients receiving ART in the clinic of NACP at Al-Jomhori Educational Hospital in Sana’a, Yemen (2019–2020)

From: Intestinal microsporidiosis among HIV/AIDS patients receiving antiretroviral therapy in Sana’a city, Yemen: first report on prevalence and predictors

Variable

N

Intestinal microsporidiosis

P-value

n (%)

OR (95% CI)

Gender

 

 Male

313

41 (13.1)

Reference

0.301

 Female

89

16 (18.0)

1.5 (0.8–2.7)

Age (years)

 

 < 40

261

39 (14.9)

0.8 (0.5–1.5)

0.653

 ≥ 40

141

18 (12.8)

Reference

Residence

    

 Rural

176

30 (17.0)

1.5 (0.8–2.6)

0.195

 Urban

222

27 (12.2)

Reference

Household size (members)

    

 < 5

159

16 (10.1)

Reference

0.059

 ≥ 5

243

41 (16.9)

1.8 (1.0–3.4)

Literacy status

    

 Illiterate

99

17 (17.2)

1.3 (0.7–2.4)

0.508

 Literate

264

37 (14.0)

Reference

Employment status

    

 Unemployed

222

36 (16.2)

1.5 (0.8–2.7)

0.195

 Employed

173

20 (11.6)

Reference

Diarrhea

    

 Yes

52

16 (30.8)

3.4 (1.7–6.6)

0.001

 No

350

41 (11.7)

Reference

Nausea

    

 Yes

91

14 (15.4)

1.1 (0.6–2.2)

0.733

 No

311

43 (13.8)

Reference

Vomiting

    

 Yes

38

9 (23.7)

2.0 (0.9–4.6)

0.088

 No

364

48 (13.2)

Reference

Abdominal pain

    

 Yes

132

23 (17.4)

1.5 (0.8–2.6)

0.223

 No

270

34 (12.6)

Reference

  1. N number examined, n number infected with intestinal microsporidiosis, HIV human immunodeficiency virus, AIDS acquired immunodeficiency syndrome, ART antiretroviral therapy, NACP National AIDS Control Program, OR odds ratio, CI confidence interval